《睡眠專業人士雜誌》
星期四, 七月 23, 2026
Sunovion Pharmaceuticals Inc. (Sunovion) today announced that Lonhala™ Magnair™ (glycopyrrolate) Inhalation Solution (25 mcg twice daily) is now available at pharmacies in the U.S. for the long-term, maintenance treatment of airflow obstruction in people with chronic obstructive pulmonary disease (COPD), including chronic bronchitis and/or emphysema. LONHALA MAGNAIR is the first […]
The stigma of COPD can prevent patients from coming forward. Here are our top insider tips on how you can make the difference. Few chronic illnesses carry a lack of awareness and a stigma like COPD. Caused primarily by tobacco use, COPD can evoke feelings of guilt, shame and regret […]
Convexity Scientific Inc has released the Flyp, a new pocket-portable, vibrating mesh nebulizer designed for respiratory conditions such as asthma and COPD. Convexity did away with everything that adds bulk: there are no disposable batteries, external power sources, masks, or tubes. Truly a nebulizer that fits in your pocket. A […]
Jeremy Orr, MD, of University of California, San Diego, has been awarded the new ATS Foundation/ResMed Research Fellowship in Noninvasive Ventilation (NIV) in COPD. Dr. Orr completed a fellowship in pulmonary and critical care medicine at UC San Diego School of Medicine, and a residency in internal medicine at UCLA’s […]
Mobi ResMed today introduced Mobi, its first ResMed-branded portable oxygen concentrator (POC). An image of the product is not available at this time. Mobi offers an industry-leading balance of oxygen delivery, weight and battery life so that millions with chronic obstructive pulmonary disease (COPD) or other respiratory condition can enjoy […]
A patient with COPD comes to you with news that she’s taking a family vacation. But, what should be an exciting event is becoming a major pain point as she stresses about managing her COPD with the strain of travel. Managing COPD is an ongoing need for patients, but it […]
The Global Initiative for Chronic Obstructive Lung Disease (GOLD) provides clear guidance for selecting medication for COPD; however, there is no clear guidance for device selection. These simple steps may help select the device that is best suited for the patient. There are clear guidelines (GOLD) on which medication is […]
Sunovion Pharmaceuticals Inc. today announced that the FDA approved the New Drug Application (NDA) for Lonhala™ Magnair™ (glycopyrrolate) Inhalation Solution (25 mcg twice daily), also known as SUN-101/eFlow®, for the long-term, maintenance treatment of airflow obstruction in people with chronic obstructive pulmonary disease (COPD), including chronic bronchitis and/or emphysema. Sunovion […]
During the recent Medtrade Fall in Atlanta, Royal Philips announced a strategic alliance with IncreMedical, a developer of high performance healthcare management solutions. The collaboration aims to optimize care models that will enable health systems, physicians and care providers through the use of post-acute care management solutions. As the number […]
In collaboration with COPD Foundation and Russell Winwood, campaign focuses on helping inspire and enable COPD patients to live a better life Ahead of World COPD Day on 十一月 15, Royal Philips, a leader in health technology, announced the launch of a global movement to raise awareness for chronic obstructive […]
